BIOMARKERS OF COAGULATION ACTIVATION IN CHILDREN WITH SICKLE CELL DISEASE | ||||
| Research Journal of Applied Biotechnology | ||||
| Article 13, Volume 3, Issue 1, June 2017, Page 47-52 PDF (346.78 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/rjab.2017.57644 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Shimaa Dawood  1; Mohamed A. Soliman2; Mona K. El-Ghamrawy3; Hisham A. Ismail1
| ||||
| 1Molecular Diagnostics Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), Sadat City University, Sadat city, Egypt | ||||
| 2Clinical Pathology Department, Faculty of Medicine, Menoufiyia University, Menoufiya, Egypt. | ||||
| 3Peditric Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt | ||||
| Abstract | ||||
| Sickle cell disease (SCD) is a multisystem disease, characterized by its multi-phenotypic diversity although being a disease caused by a single nucleotide substitution.In the present study, we measured biomarkers of coagulation activation in children with SCD. The study was performed on 50 Egyptian children with SCD and 41 age- and sex-matched controls. Complete blood picture (CBC), International normalized ratio (INR)and Partial thromboplastin time (PTT) levels were measured. Thrombin-antithrombin (TAT) plasma levels was estimated by enzyme-linked immunosorbent assay (ELISA). A statically significant increase in all of INR, PTT and TAT plasma levels were detected. We agree with the previous studies that children with SCD exhibit a hypercoagulable state. | ||||
| Keywords | ||||
| Sickle cell disease – Hypercoagulability– Thrombin-Antithrombin | ||||
|
Statistics Article View: 196 PDF Download: 434 |
||||
